Irit Snir-Alkalay

1.0k citations
8 papers · 633 indexed · h-index 5
Topics
Cancer-related Molecular Pathways (3 papers)Immune cells in cancer (2 papers)Telomeres, Telomerase, and Senescence (2 papers)
Partner nations
IsraelGermanyFinland

In The Last Decade

Irit Snir-Alkalay

8 papers receiving 620 citations

Peers

Irit Snir-Alkalay
Comparison fields: 5 of 84
  • Molecular Biology 416
  • Oncology 243
  • Cancer Research 108
  • Immunology 104
  • Physiology 100
Replace Frauke Goeman with:
Frauke Goeman Italy
Katherine M. Bever United States
Maaike Meerlo Netherlands
Matthias Schewe Netherlands
Ana Carolina Stumbo Brazil
Carsten P. Ade Germany
Barbara Zunino France
Lin Shan China
E J Beecham United States
Lisa Maria Mustachio United States
Irit Snir-Alkalay relative to Frauke Goeman Italy Frauke Goeman's profile →
Citations per field
00.5×1.5×2.5×
Frauke Goeman · 1×
Citations per year

Countries citing papers authored by Irit Snir-Alkalay

Since Specialization
Citations

This map shows the geographic impact of Irit Snir-Alkalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irit Snir-Alkalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irit Snir-Alkalay more than expected).

Fields of papers citing papers by Irit Snir-Alkalay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irit Snir-Alkalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irit Snir-Alkalay. The network helps show where Irit Snir-Alkalay may publish in the future.

Co-authorship network of co-authors of Irit Snir-Alkalay

This figure shows the co-authorship network connecting the top 25 collaborators of Irit Snir-Alkalay. A scholar is included among the top collaborators of Irit Snir-Alkalay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irit Snir-Alkalay. Irit Snir-Alkalay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 1
2 259
3 5
4 1
5 29
6 3
7 185
8 150

About Irit Snir-Alkalay

Irit Snir-Alkalay is a scholar working on Biological Psychiatry, Hematology and Dermatology, having authored 8 papers that have together received 633 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Immune cells in cancer (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). The work is most often cited by research in Oncology (243 citations), Cancer Research (108 citations) and Aging (12 citations). Irit Snir-Alkalay has collaborated with scholars based in Israel, Germany and Finland. Frequent co-authors include Yinon Ben‐Neriah, Ela Elyada, Moshe Oren, Eli Pikarsky, Thorsten Stiewe, Marco Mernberger, Zoltán Wiener, Avanthika Venkatachalam, Audrey Lasry and Robert E. Goldstein. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026